Kymera Therapeutics, Inc. (KYMR) vs Insulet Corp. (PODD)
A side-by-side comparison of Kymera Therapeutics, Inc. and Insulet Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KYMR
Kymera Therapeutics, Inc.
$104.85HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
PODD
Insulet Corp.
$135.44HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
Total return — KYMR vs PODD
growth of $100 · dividends reinvested · last 6yKYMR +230.3% (+22.0%/yr)PODD -35.3% (-7.0%/yr)KYMR compounded faster over this window
Log scale — wide-divergence pair
KYMR PODD
KYMR vs PODD: by the numbers
- •PODD is the larger company ($9.38B vs $8.62B market cap).
- •PODD is profitable (12.29% net margin) while KYMR runs a net loss (-285.41%).
- •PODD grew revenue faster over the past five years (25.13% vs 10.22% CAGR).
Metrics side by side
Valuation
| Metric | KYMR | PODD |
|---|---|---|
| P/E ratio | N/A | 25.32 |
| Forward P/E | N/A | 20.83 |
| PEG ratio | N/A | 0.24 |
| P/S ratio | 82.14 | 3.07 |
| P/B ratio | 5.71 | 6.60 |
| EV / EBITDA | N/A | 15.76 |
| FCF yield | N/A | 3.18% |
Profitability
| Metric | KYMR | PODD |
|---|---|---|
| Gross margin | 101.98% | 71.08% |
| Operating margin | -891.33% | 16.89% |
| Net margin | -285.41% | 12.29% |
| ROE | -19.85% | 26.39% |
| ROIC | -22.30% | 16.04% |
Growth (annualized)
| Metric | KYMR | PODD |
|---|---|---|
| Revenue CAGR (5Y) | 10.22% | 25.13% |
| EPS CAGR (5Y) | N/A | 99.91% |
| Total return CAGR (5Y) | 12.31% | -13.93% |
Frequently asked
- Which has grown faster, KYMR or PODD?
- Over the past five years, PODD grew revenue faster — KYMR at a 10.22% CAGR versus PODD at 25.13%.
- Is KYMR or PODD more profitable?
- PODD runs the higher net margin — KYMR at -285.41% versus PODD at 12.29%.
- How have KYMR and PODD total returns compared?
- Over the past 5 years, KYMR delivered 12.31% and PODD delivered -13.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Insulet P/E ratioKymera Therapeutics ROEInsulet ROEKymera Therapeutics operating marginInsulet operating marginKymera Therapeutics revenue growthInsulet revenue growthKymera Therapeutics free cash flowInsulet free cash flow
Kymera Therapeutics & Insulet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.